Drug-versus-Drug Adverse Event Rate Comparisons: A Pilot Study Based on Data from the US FDA Adverse Event Reporting System

By Hochberg Alan M.   Pearson Ronald K.   O'Hara Donald J.   Reisinger Stephanie J.  

Drug Safety, Vol. 32, Iss. 2, 2009-01 ,pp. : 137-146

Adis International

Access to resources Recommend Favorite

Cost of Treatment for Onychomycosis: Data from a 9-Month Observational Study

By Stier D.M.  

PharmacoEconomics, Vol. 19, Iss. 3, 2001-03 ,pp. : 267-279

Adis International

Access to resources Recommend Favorite

Predictors of 1-, 6- and 12-month smoking cessation among a community-recruited sample of adult smokers in the United States

By Harte Christopher B.   Watts Tyler W.   Meston Cindy M.  

Journal of Substance Use, Vol. 18, Iss. 5, 2013-10 ,pp. : 405-416

Radcliffe Press

Access to resources Recommend Favorite

Efficacy and Safety of Tianeptine in Major Depression: Evidence from a 3-Month Controlled Clinical Trial versus Paroxetine

By Waintraub L.  

CNS Drugs, Vol. 16, Iss. 1, 2002-01 ,pp. : 65-75

Adis International

Access to resources Recommend Favorite

Observational 6-month Open-label Study of Japanese Type 2 Diabetes Patients Switching from NPH Insulin to Insulin Detemir in Basal–Bolus Regimen: 23rd Article of the Japan Diabetes Clinical Data Management Study Group (JDDM23)

By Oishi M   Abe N   Yokoyama H   Kuribayashi N   Tomonaga O   Matoba K   Kobayashi M  

The Journal of International Medical Research, Vol. 40, Iss. 2, 2012-03 ,pp. : 787-797

Field House Publishing

Access to resources Recommend Favorite